Home › Biogen Rises on Data From Early-Stage Alzheimer's Drug Trial
 

Keywords :   


Biogen Rises on Data From Early-Stage Alzheimer's Drug Trial

2014-12-03 00:11:59| Agriculture - Topix.net

Biogen Idec Inc. shares rose after the company said its Alzheimer's drug showed promising early results and will be quickly moved into a final-stage trial. In a small, early stage trial, Biogen's drug BIIB037 reduced beta amyloid in the brain, said Doug Williams, executive vice president of research and development, at a Deutsche Bank conference in Boston today.

Tags: data trial drug rises

Category:Agriculture and Forestry

Latest from this category

All news
05.11American Angus elects 2024-25 board leaders
05.11Brazil gives green light to medicinal use of Cannabis in animals
05.11We might not like it, but overhead must be evaluated
05.11Phibro Animal Health completes acquisition of Zoetis medicated feed additive portfolio
05.11November/December 2024 Digital Edition of National Hog Farmer now available
04.11Markets appear restless
04.11American Angus Association fiscal year results show continued beef industry leadership
04.11KDA hosts beef genetics trade team from Canada
Agriculture and Forestry »
05.11PM responds to Sir Alan Bates after repeated requests
05.11American Angus elects 2024-25 board leaders
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Public Advisory Number 8A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Brazil gives green light to medicinal use of Cannabis in animals
More »